Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela

Leprosy is a slowly evolving disease that occurs mainly in adults. In this study, the Mamaría Village, state of Portuguesa was selected because it had one of the highest rates (13.25%) of leprosy cases in 1997. Between1998-2004, 20.2% of the 89 cases registered in this village were less than 15 year...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno: 2012
Témata:
On-line přístup:http://hdl.handle.net/10872/13005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
_version_ 1870621955969777664
bitstream.checksum.fl_str_mv 7c020282d630887ba819753d2e4a4c58
cfdf8b009f7e3e29f20f5b37dceca209
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
bitstream.url.fl_str_mv https://saber.ucv.ve/jspui/bitstream/10872/13005/2/license.txt
https://saber.ucv.ve/jspui/bitstream/10872/13005/1/Ig%20G%20seguimiento%20IMOC.pdf
dc.contributor.author.none.fl_str_mv Rada, Elsa
Duthie, Malcolm S
Reed, Steven G
Aranzazu, Nacarid
Convit, Jacinto
dc.creator.fl_str_mv Rada, Elsa
Duthie, Malcolm S
Reed, Steven G
Aranzazu, Nacarid
Convit, Jacinto
dc.date.accessioned.none.fl_str_mv 2015-12-08T18:19:06Z
dc.date.available.none.fl_str_mv 2015-12-08T18:19:06Z
dc.date.issued.none.fl_str_mv 2012-07-18
dc.identifier.issn.none.fl_str_mv 1678-8060
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10872/13005
dc.language.iso.es_VE.fl_str_mv en
dc.subject.es_VE.fl_str_mv leprosy
prevalencia
incidence
serology
recombinant proteins
dc.title.es_VE.fl_str_mv Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
dc.type.es_VE.fl_str_mv Article
description Leprosy is a slowly evolving disease that occurs mainly in adults. In this study, the Mamaría Village, state of Portuguesa was selected because it had one of the highest rates (13.25%) of leprosy cases in 1997. Between1998-2004, 20.2% of the 89 cases registered in this village were less than 15 years old and 61.8 % were males. Paucibacillary (PB) lesions were the predominant clinical forms identified, although also multibacillary (MB) forms were found. Additionally, 76% of the patients were bacteriologically negative. At the time of diagnosis, 75% of the patients presented with grade 0 disabilities, 23 % with grade 1 and 2 % with grade 2. Serum samples were colleted from 18 PB and 15 MB, in addition to 14 family contacts, at the beginning and end of treatment. All the groups were re-evaluated during a three-year period (2008-2011). The proteins used for evaluation were ML0405, ML2331 and LID-1. These mycobacterial proteins were highly specific for Mycobacterium leprae and the IgG responses decreased in both MB and PB patients during multidrug treatment. Our results suggest that these antigens could be used as markers for successful treatment of non-reactional lepromatous patients.
id SABERUCV_6ad351e9c56c69d97cbd6a60b09c8564
identifier_str_mv 1678-8060
language_invalid_str_mv en
network_acronym_str SABERUCV
network_name_str Repositorio Institucional de la Universidad Central de Venezuela
oai_identifier_str oai:saber.ucv.ve:10872/13005
publishDate 2012
publishDateSort 2012
repository.mail.fl_str_mv sfwrussians@gmail.com
repository.name.fl_str_mv Saber UCV
repository_id_str
spelling Rada, ElsaDuthie, Malcolm SReed, Steven GAranzazu, NacaridConvit, Jacinto2015-12-08T18:19:06Z2015-12-08T18:19:06Z2012-07-181678-8060http://hdl.handle.net/10872/13005Leprosy is a slowly evolving disease that occurs mainly in adults. In this study, the Mamaría Village, state of Portuguesa was selected because it had one of the highest rates (13.25%) of leprosy cases in 1997. Between1998-2004, 20.2% of the 89 cases registered in this village were less than 15 years old and 61.8 % were males. Paucibacillary (PB) lesions were the predominant clinical forms identified, although also multibacillary (MB) forms were found. Additionally, 76% of the patients were bacteriologically negative. At the time of diagnosis, 75% of the patients presented with grade 0 disabilities, 23 % with grade 1 and 2 % with grade 2. Serum samples were colleted from 18 PB and 15 MB, in addition to 14 family contacts, at the beginning and end of treatment. All the groups were re-evaluated during a three-year period (2008-2011). The proteins used for evaluation were ML0405, ML2331 and LID-1. These mycobacterial proteins were highly specific for Mycobacterium leprae and the IgG responses decreased in both MB and PB patients during multidrug treatment. Our results suggest that these antigens could be used as markers for successful treatment of non-reactional lepromatous patients.enleprosyprevalenciaincidenceserologyrecombinant proteinsSerologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in VenezuelaArticleLICENSElicense.txtlicense.txttext/plain; charset=utf-81509https://saber.ucv.ve/jspui/bitstream/10872/13005/2/license.txt7c020282d630887ba819753d2e4a4c58MD52ORIGINALIg G seguimiento IMOC.pdfIg G seguimiento IMOC.pdfapplication/pdf766229https://saber.ucv.ve/jspui/bitstream/10872/13005/1/Ig%20G%20seguimiento%20IMOC.pdfcfdf8b009f7e3e29f20f5b37dceca209MD5110872/13005oai:saber.ucv.ve:10872/130052015-12-08 18:19:06.315Saber UCVsfwrussians@gmail.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
spellingShingle Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
leprosy
prevalencia
incidence
serology
recombinant proteins
title Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
title_full Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
title_fullStr Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
title_full_unstemmed Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
title_short Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
title_sort Serologic follow-up of IgG responses against recombinat mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela
topic leprosy
prevalencia
incidence
serology
recombinant proteins
url http://hdl.handle.net/10872/13005